Navigation Links
Inverness Medical Innovations Announces September Investor Conference Schedule
Date:9/10/2009

WALTHAM, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend several healthcare industry investor conferences during the month of September.

  • Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend the Morgan Stanley Global Healthcare Conference being held on September 14 and 15, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central. Mr. Zwanziger's presentation is scheduled for Monday, September 14, 2009 at 2:45 p.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the Morgan Stanley Conference website at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=IMA&item_id=2400719.
  • Mr. Zwanziger and Mr. Russell will attend the Stifel Nicolaus/Johns Hopkins Annual Healthcare Symposium being held at the Hilton, Baltimore, Maryland on Tuesday, September 15, 2009. This symposium will not be webcast.
  • Mr. Russell will attend ThinkEquity's 6(th) Annual Growth Conference being held at the St. Regis, San Francisco on Wednesday, September 16. Mr. Russell's presentation is scheduled for 9:30 a.m., and will not be webcast.
  • Mr. Zwanziger and Mr. Russell will attend the UBS Global Life Sciences Conference being held on September 21 through the 23, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central. Mr. Zwanziger's presentation is scheduled for Tuesday, September 22, 2009 at 11:30 a.m. and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the UBS Conference website at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=143_EFSBJ3O.

During their presentations, Mr. Zwanziger and Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcasts, may contain or constitute information that has not been disclosed previously. Replays of the webcasts will be available via the links indicated above for 30 days.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
2. Inverness Medical Innovations to Present at the Canaccord Adams Global Growth Conference on August 11, 2009
3. Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes
4. CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients
5. Inverness Medical Innovations Announces Second Quarter 2009 Results
6. Inverness Medical Innovations Proposes to Acquire Concateno plc
7. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
8. Inverness Medical Innovations to Present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009
9. Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009
10. Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes
11. Inverness Medical Innovations Announces First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017   Divoti USA will engrave and ... standard of the latest FDA requirements, which stipulates new criteria regarding ... in need of Medical ID jewelry such as Medical ID Bracelets, ... engraved in terms of the new FDA requirements . ... Divoti offers this dark mark fiber ...
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
Breaking Medicine Technology: